Enhertu: The New Oncology ‘Smart Bomb’
An article on Health.com recently quoted me about an exciting new FDA-approved drug shown to extend metastatic breast cancer patients’ lives significantly. Enhertu is a combination of two known therapies, trastuzumab and deruxtecan work in tandem to target the lower levels of HER2 proteins present. As I described in the article, these two therapies work […]
Enhertu: The New Oncology ‘Smart Bomb’ Read More »
